NCT03423992 2021-06-15Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant GliomasXuanwu Hospital, BeijingPhase 1 Unknown100 enrolled
NCT03638206 2019-12-11Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesShenzhen BinDeBio Ltd.Phase 1/2 Unknown73 enrolled